Purpose of this modification is to: 1. Accept transfer accountability of 5,015,690 vials (50.1 million doses) of AS03 adjuvant from contract # W15QKN-20-C-0048 to contract # 75A50122D00002 2. Add…
Ended Awarded Last action
- Contract number
- 75A50123F61005
- Awardee
-
Glaxosmithkline, LLC UEI FRHTPHMZMX47
- Awarding agency
-
Office of the Assistant Secretary for Preparedness and Response
Department of Health and Human Services
- Obligated
- $4,680,600
Award facts
- Contract value 100% obligated
- $4,680,600.49 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 541714 Research and Development in Biotechnology (except Nanobiotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Marietta, PA 17547, USA
- Legislative mandates
-
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Close Out | -$0 | |
| Other Administrative Action | $0 | |
| Original award | $4,680,601 |
About this award
The Office of the Assistant Secretary for Preparedness and Response issued a delivery order with a $4.68 million ceiling to Glaxosmithkline, LLC on December 12, 2022, with no set-aside and firm fixed-price pricing. Place of performance is Marietta, PA 17547. The order's period of performance, as corrected by a no-cost modification for CLINs 3000 and 6000, runs February 22, 2022 through February 21, 2024, and the ultimate completion date is February 21, 2024. One modification transfers accountability of 5,015,690 vials (50.1 million doses) of AS03 adjuvant from contract W15QKN-20-C-0048 to contract 75A50122D00002 and adds $1,038,708.00 in funding. The no-cost modification also updates the contracting officer.
Description
Purpose of this modification is to: 1. Accept transfer accountability of 5,015,690 vials (50.1 million doses) of AS03 adjuvant from contract # W15QKN-20-C-0048 to contract # 75A50122D00002 2. Add funding in the amount of $1,038,708.00 for 33 BUL
Quick answers
Who was awarded contract 75A50123F61005?
75A50123F61005 was awarded to Glaxosmithkline, LLC by Office of the Assistant Secretary for Preparedness and Response (Department of Health and Human Services) on December 12, 2022.
How much is contract 75A50123F61005 worth?
The government has obligated $4,680,600 on 75A50123F61005.
Is contract 75A50123F61005 an order under another contract?
Yes. 75A50123F61005 is a delivery order under 75A50122D00002, an indefinite delivery contract.
Was contract 75A50123F61005 competed?
The extent of competition for 75A50123F61005 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award